Clinical Trials Browser

Phase 3 × INDUSTRY × exatecan × Clear all

NCT00023972 2012-05-16

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms